RSCM
NBRV

Rock Springs Capital Management’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Rock Springs Capital Management’s Portfolio NBRV Stock Details NBRV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-4,271
Closed -$569K – 166
2020
Q3 		$569K Hold
4,271
– – 0.01% 147
2020
Q2 		$720K Buy
4,271
+71
+2% +$11.8K 0.02% 141
2020
Q1 		$604K Sell
4,200
-4,200
-50% -$1.28M 0.03% 130
2019
Q4 		$2.77M Sell
8,400
-800
-9% -$367K 0.09% 115
2019
Q3 		$4.6M Buy
9,200
+2,800
+44% +$1.58M 0.18% 108
2019
Q2 		$3.89M Hold
6,400
– – 0.14% 116
2019
Q1 		$3.9M Hold
6,400
– – 0.15% 111
2018
Q4 		$2.34M Sell
6,400
-800
-11% -$430K 0.11% 120
2018
Q3 		$4.86M Buy
7,200
+4,640
+181% +$3.29M 0.18% 119
2018
Q2 		$2.23M Buy
2,560
+60
+2% +$68.7K 0.09% 133
2018
Q1 		$3.14M Hold
2,500
– – 0.13% 133
2017
Q4 		$3.74M Hold
2,500
– – 0.17% 117
2017
Q3 		$5.12M Buy
2,500
+400
+19% +$938K 0.24% 103
2017
Q2 		$5.5M Hold
2,100
– – 0.28% 93
2017
Q1 		$6.3M Hold
2,100
– – 0.36% 79
2016
Q4 		$3.12M Buy
2,100
+396
+23% +$526K 0.21% 96
2016
Q3 		$3M Hold
1,704
– – 0.19% 107
2016
Q2 		$3.19M Buy
1,704
+184
+12% +$371K 0.24% 103
2016
Q1 		$3.4M Buy
1,520
+580
+62% +$1.25M 0.29% 95
2015
Q4 		$2.24M Sell
940
-358
-28% -$873K 0.17% 108
2015
Q3 		$3.08M Buy
+1,298
New +$3.44M 0.25% 104

Other funds holding NBRV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
AICPI
ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return

Rock Springs Capital Management's NBRV Position: Q4 2020 in Review

Rock Springs Capital Management sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q4 2020, closing a stake of 4,271 shares — an estimated $569K sold.

Rock Springs Capital Management first reported a position in NBRV in Q3 2015 and held it in 21 quarters. The position peaked at $6.3M in Q1 2017. 33 funds tracked by Wall St. Rank hold NBRV as of Q4 2020.

  • Rock Springs Capital Management reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q4 2020 after selling out during the quarter.
  • Rock Springs Capital Management sold 4,271 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q4 2020, an estimated $569K.
  • Rock Springs Capital Management first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q3 2015 and held it in 21 quarters.
  • Rock Springs Capital Management's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $6.3M in Q1 2017.
  • 33 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q4 2020.

Based on Rock Springs Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.